Quantcast

Latest Therapies under investigation for multiple sclerosis Stories

2010-02-16 16:24:53

An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis.

2010-02-16 13:47:57

According to data published in the Lancet Neurology, daclizumab combined with interferon beta reduced MS lesion formation 72 percent more than interferon beta alone.

2009-12-07 14:48:58

Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in clinical trials for multiple sclerosis (MS) and rheumatoid arthritis (RA).

2009-08-31 11:28:57

According to data supplied by the German Multiple Sclerosis Society’s national MS register (DMSG - Deutsche Multiple Sklerose Gesellschaft), up to 10% of German MS patients have been treated with mitoxantrone in the past few years.

2009-08-25 10:49:00

CAMBRIDGE, Mass., Aug. 25 /PRNewswire/ -- Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS).

2009-06-19 00:17:31

Twenty-seven percent of multiple sclerosis patients are declining to fill their prescriptions, U.S.

2009-04-29 07:00:00

SEATTLE, April 29 /PRNewswire/ -- New analyses of data from the 16-Year Long-term Follow-up study with Betaseron(R) (interferon beta-1b), sponsored by Bayer HealthCare Pharmaceuticals, were presented at the American Academy of Neurology's (AAN) 61st Annual Meeting.


Word of the Day
scriggle
  • To writhe; struggle or twist about with more or less force; wriggle.
  • To scribble, jot.
The word 'scriggle' is likely an alteration of 'wiggle'.
Related